PCN57 COST-UTILITY ANALYSIS OF ADJUVANT GOSERELIN AND ADJUVANT CHEMOTHERAPY IN PATIENTS WITH PREMENOPAUSAL BREAST CANCER
May 1, 2008, 00:00 AM
10.1016/S1098-3015(10)70235-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)70235-7/fulltext
Section Title :
Section Order :
885
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70235-7&doi=10.1016/S1098-3015(10)70235-7